← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2006Last known activity
Sep 1, 2023
Timeline
1990s
- Jan 1, 1997
Ophthalmic Consultants of Long Island— Founded
Drugs by trial phase (16 distinct, 15 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT06539637OfficialEarly Phase 1Sep 1, 2023
- NCT04205916Lead sponsorPhase 4Nov 4, 2019
- NCT02547623Overall official - principal investigatorPhase 3Oct 1, 2015
- NCT01813773Lead sponsorPhase 2/Phase 3Mar 1, 2013
- NCT01813773Overall official - principal investigatorPhase 2/Phase 3Mar 1, 2013
- NCT01244334Overall official - principal investigatorPhase 4Mar 1, 2009
- NCT00824070Overall official - principal investigatorPhase 1Feb 1, 2009
- NCT00799682Lead sponsorPhase 4Oct 1, 2008
- NCT00799682Overall official - principal investigatorPhase 4Oct 1, 2008
- NCT00799682Study directorPhase 4Oct 1, 2008
- NCT00627302Overall official - principal investigatorPhase 4Feb 1, 2008
- NCT00433225Overall official - principal investigatorPhase 4Feb 7, 2007
- NCT00607776Overall official - principal investigatorPhase 2Jan 1, 2007
- NCT00407043Study directorPhase 4Nov 1, 2006
- NCT00407043Lead sponsorPhase 4Nov 1, 2006
Details
- Founded
- Lynbrook, NY, US Jan 1, 1997
- Last known activity
- Sep 1, 2023